Parkinson's Disease (PD) affects over 10 million people worldwide and is the second most common neurodegenerative disorder1,2. Key research areas include genetics studies of patients with PD, target optimization for new treatments, the biology of cellular signaling pathways (α-synuclein, LRRK2, GBA, PRKN/PINK1, inflammation, and mitochondrial dysfunction), biomarkers for PD onset and progression, and new imaging techniques to measure brain changes and activity. The Parkinson's Progression Markers Initiative... Read More